About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Phoenix | 27 Studies

Clinical Trials SchizophreniaPhoenix

Schizophrenia Clinical Trials in Phoenix

Find 27 clinical trials for schizophrenia near Phoenix, Arizona. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 27 trials

TerminatedStudy to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaStudy to evaluate the safety and efficacy of luvadaxistat compared with placebo on improving cognitive performance in participants with schizophrenia.NCT05182476·Phoenix, Arizona and 48 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisML-007C-MA-221 is a Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ML-007C-MA in male and female participants aged 55 to 90…NCT06887192·Phoenix, Arizona and 54 others

RecruitingSafety and Efficacy of Brilaroxazine (RP5063) in SchizophreniaThis study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term.NCT05184335·Phoenix, Arizona and 17 others

TerminatedExtension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaTo evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophreniaNCT03121586·Phoenix, Arizona and 160 others

TerminatedA Study of MP-101 in Dementia-Related Psychosis and/or Agitation and AggressionA ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and AggressionNCT03044249·Phoenix, Arizona and 19 others

CompletedPEARL Schizophrenia MaintenanceLurasidone HCI is a compound that is FDA-approved for the treatment of schizophrenia.NCT01435928·Springdale, Arizona and 74 others

CompletedA Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaThe primary objective of the study is to evaluate the long-term safety and tolerability of TV-46000.NCT03893825·Phoenix, Arizona and 89 others

CompletedAn Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaThis is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with…NCT05304767·Phoenix, Arizona and 93 others

RecruitingA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis…NCT06585787·Chandler, Arizona and 295 others

CompletedA Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaThis is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequate response to their current…NCT05145413·Phoenix, Arizona and 165 others

UnknownEvaluation of Programs of Coordinated Care and Disease ManagementThis is a Congressionally mandated study.NCT00627029·Phoenix, Arizona and 14 others

CompletedAn Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in de novo subjects with…NCT04820309·Little Rock, Arkansas and 116 others

CompletedEfficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of the negative symptoms of schizophreniaNCT02970305·Phoenix, Arizona and 100 others

CompletedStudy of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of SchizophreniaThis study evaluates the efficacy of two prescription digital therapeutics (PDT) in addition to standard of care (SOC) therapy for the treatment of experiential negative symptoms…NCT05838625·Chandler, Arizona and 53 others

TerminatedA Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®To compare inpatient psychiatric hospitalization rates while participants are on oral standard-of-care antipsychotic treatment and later switched to Abilify MyCite®.NCT03892889·Phoenix, Arizona and 67 others

TerminatedA Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaThe primary purpose of this study is to assess the long-term safety and tolerability of oral emraclidine in adult participants with schizophrenia.NCT05443724·Phoenix, Arizona and 84 others

CompletedJourney Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for SchizophreniaThe primary objective for this study is to evaluate the effect of adjunctive valbenazine versus placebo on symptoms of schizophrenia in participants who have inadequate response…NCT05110157·Phoenix, Arizona and 86 others

CompletedA Comparison of Seroquel vs. Risperidone in SchizophreniaThe purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.NCT00034905·Birmingham, Alabama and 63 others

TerminatedTreatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeThis is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.NCT00160147·Phoenix, Arizona and 50 others

CompletedA Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease PsychosisThis study will evaluate the safety and efficacy of two dose levels of pimavanserin (ACP-103) compared to placebo in patients with Parkinson's disease psychosis.NCT00477672·Gilbert, Arizona and 77 others

Page 1 of 2Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia